⌘K

Login Start Free

Home/Filings/4/0001193125-25-223667

4//SEC Filing

Powl Brian T. 4

Accession 0001193125-25-223667

CIK 0001422143other

View on SEC.gov Company Profile

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 7:30 PM ET

Size

6.1 KB

Accession

0001193125-25-223667

Insider Transaction Report

Form 4

Period: 2025-09-27

Kura Oncology, Inc.KURA

Chief Commercial Officer

Transactions

Award
Common Stock
2025-09-27+48,900→ 108,567 total
Sale
Common Stock
2025-09-29$8.94/sh−8,891$79,505→ 99,676 total

Footnotes (1)

[F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1

filerCIK 0001934232

Filing Metadata

Form type: 4
Filed: Sep 28, 8:00 PM ET
Accepted: Sep 29, 7:30 PM ET
Size: 6.1 KB

View on SEC.gov